Formulation of Pharmaceuticals and Biologics – Chair: Ulla Elofsson

C-43 – Dr Grit Baier, BASF – FORMULATION OF ENZYMES FOR INDUSTRIAL APPLICATIONS
C-47 – Sebastian Hansson, SOLVE Research & Consultancy AB – LABEL-FREE CHARACTERISATION OF BIOLOGICAL DRUGS IN PLASMA
C-13 – Chi Zhang, University of Manchester – FORMULATION OF ENVIRONMENTALLY FRIENDLY COSMETIC CREAMS
C-27 – Dr Martin Edwards, Britest Limited – A SYSTEMS-BASED APPROACH TO DIGITAL DESIGN AND OPERATION IN THE FORMULATION OF PHARMACEUTICALS
C-33 – Dr Alison Savage, University of Liverpool – FORMULATION OF DUAL COMPONENT SOLID DRUG NANOPARTICLES FOR IMPROVED ORAL BIOAVAILABILITY OF DARUNAVIR AND RITONAVIR
C-46 – Prof Alain Durand, Université de Lorraine CNRS – CHARACTERIZATION OF COMMERCIAL PHARMACEUTICAL TABLETS AND MODEL BINARY MIXTURES TOWARD AN IMPROVED UNDERSTANDING OF TREATMENT EFFICIENCY